ABSTRACT
Lung growth to its optimal size at birth is driven by reiterative airway branching followed by differentiation and expansion of alveolar cell types. How this elaborate growth is coordinated with the constraint of the chest is poorly understood. Here, we investigate the role of Hippo signaling, a cardinal pathway in organ size control, in mouse lung development. Unexpectedly, we found that epithelial loss of the Hippo kinase genes Lats1 and Lats2 (Lats1/2) leads to a striking reduction of lung size owing to an early arrest of branching morphogenesis. This growth defect is accompanied by abnormalities in epithelial cell polarity, cell division plane and extracellular matrix deposition, as well as precocious and increased expression of markers for type 1 alveolar epithelial cells (AEC1s), an indicator of terminal differentiation. Increased AEC1s were also observed in transgenic mice with overexpression of a constitutive nuclear form of downstream transcriptional effector YAP. Conversely, loss of Yap and Taz led to decreased AEC1s, demonstrating that the canonical Hippo signaling pathway is both sufficient and necessary to drive AEC1 fate. These findings together reveal unique roles of Hippo-LATS-YAP signaling in the developing mouse lung.
INTRODUCTION
The mechanical properties of the developing lung undergo dynamic changes in utero. Early on during pseudoglandular branching, proliferating epithelial cells jostle for space within the growing monolayer and push against surrounding mesenchymal cells and extracellular matrix (ECM) to extend the epithelial tips following a stereotypical program (Metzger et al., 2008; Lefevre et al., 2017). Later, during canalicular branching and sacculation, fluid pressure in both the epithelial lumen and plural space between the lung and the chest wall leads to an increase in mechanical pressure on all cell types in the lung. After birth, fluid is replaced with air, which, with each breath, exerts tidal pressure on lung cell types. How these dynamic mechanical properties impact cell proliferation, apical-basal polarity and cell fate choices during lung development remains poorly understood.
The Hippo signaling pathway is a conserved kinase cascade that senses the cellular environment, such as matrix stiffness, to regulate diverse cellular processes, including cell proliferation, movement, polarity and differentiation (Pan, 2010; Piccolo et al., 2014; Mo et al., 2014). There is emerging evidence that Hippo signaling controls the expression of genes responsible for ECM production, including Ctgf, Cyr61 and Lama5, demonstrating a feedback mechanism (Zhao et al., 2008; Chang et al., 2015). Canonical Hippo pathway components include the upstream kinases MST1 and MST2 (STK3) that phosphorylate LATS1/2, which in turn phosphorylate YAP/TAZ, leading to their retention in the cytoplasm and subsequent degradation. When Hippo signaling is disrupted, the kinases are inactive, therefore unphosphorylated YAP/TAZ proceed to enter the nucleus and form a complex with transcriptional co-factors to influence target gene transcription. YAP/TAZ transcriptional targets often include positive regulators of cell proliferation and negative regulators of cell death. Thus, inactivation of Hippo signaling leads to enlarged organ size, a signature phenotype of the pathway (Pan, 2010; Mo et al., 2014).
Several recent studies investigated the roles of Hippo pathway in lung development and compensatory re-growth after pneumonectomy by inactivating either Yap or Mst1/2 (Lin et al., 2015; Chung et al., 2013; Lange et al., 2015; Liu et al., 2016). The results have led to conflicting conclusions and left gaps in knowledge. For example, in the Mst1/2 deletion mutants, one study showed that both type 1 (AEC1) and type 2 (AEC2) alveolar epithelial cells are decreased and YAP phosphorylation is not affected (Chung et al., 2013), whereas others show that AEC1 and AEC2 number are differentially affected and YAP phosphorylation is affected (Lange et al., 2015; Lin et al., 2015). There is not a major change in organ size in any of the Mst1/2 mutants.
To clarify and substantiate how Hippo signaling affects the developing lung epithelium, we investigated the role of Lats1/2, which encode the most proximal kinases to YAP, by inactivating these genes in the lung epithelium. Early inactivation at the start of lung development led to a drastic decrease, rather than the expected increase of lung size. Although lung specification did occur, Lats1/2 mutant lungs showed the most profound branching disruption observed in all Hippo pathway lung mutants examined to date. Accompanying the branching defect was a striking precocious expression of AEC1 markers. This promotion of terminal differentiation of the squamous AEC1 cell fate is recapitulated in constitutive nuclear YAP overexpression during sacculation. In contrast, there is a decrease in AEC1 markers in YAP/TAZ loss-of-function mutants. Our results suggest that proper Hippo signaling is crucial for proper control of AEC1 fate as the lung transitions to the extra-uterine environment.
RESULTS
Lats1/2 inactivation led to a minute lung with complete halt of secondary branching morphogenesis
We quantified transcript levels of Lats1 and Lats2 in embryonic day (E) 11.5, E15.5 and E18.5 control lungs and found that Lats1 and Lats2 mRNA levels remain relatively constant throughout development (Fig. S1). To determine whether Lats1 and Lats2 are required for lung development, we generated mice with loss of Lats1 and Lats2 in the developing lung epithelium, using Shhcre, which drives robust Cre activity in the lung epithelium starting at lung specification (Shhcre;Lats1del/fl;Lats2del/fl; hereafter Shhcre;Lats mutants) (Harris et al., 2006). Although loss of LATS is known to result in grossly increased organ size in multiple contexts, among a number of gross morphological defects, Shhcre;Lats mutant lungs were greatly reduced in size at E18.5 (Fig. 1A, Fig. S2) (Dong et al., 2007; Camargo et al., 2007). This unexpected result, along with previous studies suggesting that Hippo signaling may not act through YAP in the developing lung, led us to investigate whether canonical Hippo signaling is disrupted in Shhcre;Lats mutants (Chan et al., 2013). At E11.5, phosphorylated YAP (p-YAP) was detected in the cytoplasm of epithelial and mesenchymal cells in control lungs (Fig. 1B), and was near absent specifically in the epithelial cells in Shhcre;Lats mutants (Fig. 1C). At E10.5 and E11.5 in control lungs, total YAP was detected throughout the nucleus and cytoplasm of epithelial and mesenchymal cells (Fig. 1D, Fig. S3A). In Shhcre;Lats lungs, although mesenchymal expression remains unchanged, YAP was present exclusively in the nucleus in epithelial cells (Fig. 1E, Fig. S3B). Additionally, whole-lung qRT-PCR analysis indicated that transcript levels of YAP target genes, such as Ctgf and Amotl2, were increased in Shhcre;Lats mutants, suggesting that YAP transcriptional activity is increased (Fig. S3C). These data suggest that in the developing lung epithelium, LATS is required for phosphorylation and cytoplasmic retention of YAP.
To address the cause of size reduction, we traced the phenotype to earlier stages. In E10.5 Shhcre;Lats mutants, NKX2-1 expression was unchanged, suggesting that the lung fate is properly specified (Fig. S3D,E). Primary budding occurred in the mutant; however, by E11.5 primary lung buds failed to undergo secondary branching morphogenesis (Fig. 1F-H). Additionally, the epithelium of Shhcre;Lats mutant lungs appeared multilayered, with disorganized cells extruding into the lumen (Fig. 1I-N). This complete halt of secondary branching morphogenesis is much more severe than that in Shhcre;Mst1;Mst2 (hereafter Shhcre;Mst) mutants, in which growth defects were first detected during sacculation (Lin et al., 2015; Chung et al., 2013; Lange et al., 2015). Also different from the Shhcre;Mst mutants, cell proliferation was unchanged in the epithelium of Shhcre;Lats mutant lungs (Fig. S4A-C). In contrast, apoptotic cell death was increased, especially in the extruded luminal cells (Fig. S4D,E). These data indicate that loss of Lats1/2 led to one of the strongest phenotypes yet observed among lung development mutants, and had a much more severe impact than loss of their upstream kinases, Mst1/2.
Lats1/2 are required for proper proximal/distal lung patterning
To determine whether the branching defect is also accompanied by a patterning defect, we stained E11.5 lungs with anti-SOX2 and anti-SOX9 antibodies as proximal and distal markers, respectively. In contrast to a robust expression of these markers in the control, in the Shhcre;Lats mutants, SOX2 was weakly detected in a proximal subset of epithelial cells that extruded apically into the lumen, whereas SOX9 was weakly detected in a distal subset of the epithelial cells that were positioned more basally in the abnormally multilayered epithelium (Fig. 2A,B). The reduction of staining for SOX9 protein was corroborated by whole-lung qRT-PCR of Sox9 transcripts (Fig. 2C), even though the expression change in the epithelium may be dampened by persisting expression in the mesenchyme. The level of Sox2 transcripts also appeared to be decreased although this was not statistically significant (Fig. 2C). Similarly disrupted SOX2 and SOX9 expression was also observed at E12.5, although SOX2 expression appeared to be higher than at E11.5 (Fig. 2D,E). These results indicate that both proximal and distal markers are present, but compromised, in the Shhcre;Lats mutants.
Additionally, we investigated the expression of Bmp4 and Fgf10, essential factors for branching morphogenesis. Bmp4 was expressed in the distal epithelium of control lungs at E12.5 (Fig. 2F) and was absent from the epithelium of Shhcre;Lats mutants (Fig. 2G). Conversely, Fgf10 was expressed in the distal mesenchyme of control lungs at E11.5 (Fig. 2H) and was expanded in the mesenchyme of Shhcre;Lats mutants (Fig. 2I). These data suggest that the expression of key branching factors Bmp4 and Fgf10 is disrupted downstream of LATS.
Lats1/2 are required for proper apical-basal polarity in the developing lung
To determine the cellular mechanism underlying branching and patterning defects, we examined several markers of basic cellular properties. E-cadherin (CDH1), the major component of adherens junctions, is required for proper branching in the submandibular gland and mammary gland (Walker et al., 2008; Boussadia et al., 2002). In the control lung, as expected, E-cadherin staining was more intense in the apical-lateral surfaces than the basal surface. In Shhcre;Lats mutant lungs, there was a loss of the apical bias and an increase of staining intensity in the basal epithelium (Fig. 3A-D). This increase in staining was corroborated by qRT-PCR results showing elevated transcripts (Fig. 3E).
The altered subcellular localization of E-cadherin suggests that apical-basal polarity may be disrupted in Shhcre;Lats mutants. Disruptions in apical-basal polarity also led to defective branching morphogenesis in multiple organs, including the lung (Yates et al., 2013; Chen et al., 2010). In control lungs at E11.5, atypical protein kinase C (aPKC) was detected with a consistent intensity bias in the apical domain of epithelial cells. In contrast, aPKC was detected throughout the entire epithelium in Shhcre;Lats mutants (Fig. 3F,G). Conversely, scribble (SCRIB) was detected with a consistent bias in the basolateral domain of control epithelial cells, and was detected in a disorganized pattern in the epithelium of Shhcre;Lats mutants (Fig. 3H,I), such that some cells had decreased SCRIB expression, whereas others had cortical SCRIB expression. Apical-basal polarity is often linked to deposition of basement membrane proteins. In the control, laminin α5 was restricted to the basement membrane underlying the epithelium at E11.5. However, in the mutant, it was extended apically through the lateral space between cells (Fig. 3J,K).
The gross phenotype of Shhcre;Lats mutants resembles that of the Shhcre;Itgb1 mutants, in which the integrin β1 (Itgb1) gene is inactivated in the developing lung epithelium (Chen and Krasnow, 2012). We found that integrin β1 (ITGB1) protein is expressed in a similar pattern in the control and in Shhcre;Lats mutants (Fig. 3L,M). Conversely, YAP was expressed in a similar pattern to control in the Shhcre;Itgb1 mutant (Fig. S5). These data suggest that ITGB1 and LATS function in parallel to maintain the single-layer epithelium in the developing lung.
Taken together, these findings demonstrate that Shhcre;Lats mutants have altered localization of specific adhesion molecules, apical-basal polarity determinants and ECM/basement membrane components. These disrupted elements are likely to be contributing factors to the halt of branching in these mutants.
Lats1/2 are required for proper mitotic spindle angle during epithelial proliferation
The alterations in apical-basal polarity may lead to a greater propensity of the mutant epithelial cells to divide at an angle perpendicular to the basement membrane, resulting in the multilayered epithelium in Shhcre;Lats mutants. To test this possibility, we outlined the dividing spindle with γ-tubulin and α-tubulin antibodies in E11.5 lungs. Whereas the majority of control epithelial cells divided parallel to the basement membrane (θ<30) to extend the epithelium lengthwise, the majority of Shhcre;Lats mutant epithelial cells divided perpendicular to the basement membrane (60<θ<90). Additionally, whereas the dividing spindles were mostly found near the apical surface in control lungs, they were found more randomly throughout the epithelium in the mutant lungs (Fig. 3N-W). This change in cell division could contribute to the accumulation of extra cell layers as well as failed tube elongation, which is key to branching morphogenesis.
Lats1/2 are required to restrict AEC1 cell differentiation
Because inactivation of Shhcre;Lats led to early arrest of branching morphogenesis, we investigated whether this also prevented all epithelial cell differentiation. At E18.5, when control lungs expressed markers of differentiated club cells (SCGB1A1), ciliated cells (FOXJ1), AEC2s (pro-SPC) and AEC1s (HOPX and PDPN), only AEC1 markers were detected in the Lats1/2 mutant lungs (Fig. 4A-H). In the control, basal markers such as P63 (TRP63) and KRT5 were primarily restricted to the trachea, with little signal in the lung (Fig. 4I-K). In the mutant lung, however, we detected a small number of cells with a low level of P63 expression (Fig. 4L-N). There was very little overlap of P63 and HOPX expression (Fig. 4O-T). Of the few cells that were double positive for P63 and HOPX, it appeared that there was reduced HOPX expression compared with neighboring P63-HOPX+ cells (Fig. 4R-T, arrows). These findings indicate that loss of Lats leads to ectopic induction of both AEC1s and basal cells, the two epithelial cell types that show squamous morphology in the lung. It is notable that the ectopic AEC1s showed a more intense staining of the AEC1 marker HOPX in the mutant than in normal AEC1s in the control (Fig. 4P,Q,S,T), whereas the ectopic basal cells showed a less intense staining of basal markers in the mutant than in normal basal cells in the control (Fig. 4I-N).
In a normal lung, AEC1s are made in the distal alveolar region, whereas basal cells are made in the trachea, proximal to the lung. In the Shhcre;Lats mutant lung, the bias towards making ectopic AEC1s and fewer ectopic basal cells may be due to pre-existing distal patterning. To address this possibility, we assayed for the presence of these markers in the trachea where there is normally robust basal cell marker expression and little AEC1 marker expression. The trachea region of the Shhcre;Lats mutant had disrupted architecture with a large number of protruding cells filling the lumen (Fig. S6A-D). Many of the ectopic cells in Shhcre;Lats mutants expressed nuclear YAP, most of which also expressed HOPX. Similar to the lung, very few of the ectopic AEC1 cells expressed P63 (Fig. S6N-P). Although the trachea architecture was severely disrupted in Shhcre;Lats mutants, very little cell death was observed at E18.5 (Fig. S6Q,R). Together, the results from the trachea and lung suggest that when Lats1/2 are lost, epithelial cells have the propensity to differentiate into either AEC1s or basal cells, with a preference towards AEC1s.
We traced the ectopic AEC1 phenotype to earlier stages. To our surprise, antibody staining revealed a striking premature expression of AEC1 markers HOPX and PDPN in mutant lungs at E11.5 (Fig. 4U,V). The increase was confirmed by qRT-PCR of multiple AEC1 markers (Fig. 4W) and was observed as early as E10.5, making it one of the earliest phenotypes observed in this mutant (Fig. 4X,Y).
Nuclear YAP is sufficient to induce expression of AEC1 markers
As there is a significant increase of nuclear YAP in the Shhcre;Lats mutant epithelium, we investigated whether this is sufficient to induce AEC1 fate. We generated mice with inducible expression of activated YAP in the lung epithelial cells, by breeding tetO-YAPS127A to Sftpc-rtTA mice (hereafter Sftpc-rtTA;tetO-YAPS127A mutants). In the alveolar region, when induced with doxycycline beginning at E15.5, a stage during which bipotent AEC1/AEC2 progenitors are first described (Desai et al., 2014), Sftpc-rtTA;tetO-YAPS127A mutants exhibited increased AEC1s and decreased AEC2s compared with controls (Fig. 5A-N). Furthermore, 92.17% (±4.32%) of the cells with strong expression of nuclear YAP in Sftpc-rtTA;tetO-YAPS127A mutants expressed the AEC1 marker HOPX, whereas only 2.05% (±0.71%) expressed the AEC2 marker pro-SPC (Fig. 5O). This induction of AEC1 cells was not restricted to the alveolar region. In the airway, cells in the Sftpc-rtTA;tetO-YAPS127A mutant airway that strongly expressed nuclear YAP also expressed HOPX (Fig. S7), suggesting that the airway epithelium may retain some ability to differentiate into alveolar epithelial cell types at late stages of embryonic lung development. It is important to note that mutant cells with increased nuclear YAP expression did not proliferate at a higher frequency than control cells (control: 1.68±0.35%, n=3; Sftpc-rtTA;tetO-YAPS127A mutant: 1.24%±0.23%, n=4) (Fig. S8), suggesting that the increase in AEC1s is not due to increased proliferation.
YAP and TAZ are necessary for AEC1 differentiation
The finding that nuclear Yap can induce AEC1 formation is consistent with the emergence of nuclear YAP in AEC1 cells as development proceeds into the adult (Fig. S9) (Liu et al., 2016). To determine whether Yap/Taz are also necessary for AEC1 differentiation, we generated mice with inducible loss of Yap and Taz in lung epithelial cells, by generating Sftpc-rtTA;tetO-cre; Yapfl/fl;Tazfl/fl mice (hereafter Sftpc-rtTA;tetO-cre;Yap;Taz mutants). When induced at E16.5, there was a decreased number of HOPX+ AEC1s in Sftpc-rtTA;tetO-cre;Yap;Taz mutants (Fig. 6A-C). The few cells that were able to differentiate into AEC1s in Sftpc-rtTA;tetO-cre;Yap;Taz mutants retained YAP nuclear expression, suggesting that they have escaped recombination (Fig. S10). The percentage of AEC2 cells out of total cells was not altered (Fig. 6D-F). Sftpc-rtTA;tetO-cre; Yapfl/fl;Tazfl/+ lungs showed an intermediate phenotype, with fewer AEC1s than control mice, but more than Sftpc-rtTA;tetO-cre;Yap;Taz mutants, suggesting that YAP and TAZ act redundantly to promote full AEC1 differentiation (Fig. S10G-L).
DISCUSSION
Hippo signaling is most recognized for its role in regulating organ size. Specifically, disruption of the Hippo pathway kinase genes Lats1/2 or Mst1/2, or their homologs hippo and warts in Drosophila, resulted in increased proliferation and decreased cell death, leading to larger organs (Pan, 2010). In the present study, we found that despite nuclear YAP localization in the epithelium, Shhcre;Lats mutants had smaller lungs, with a clear halt of development after primary branch formation, one of the more severe lung developmental phenotypes. Likely contributors to this defect are the disrupted localization of apical-basal polarity determinants, cell adhesion molecules and ECM components, and misorientation of the spindles of dividing cells. Instead of a single-cell layer epithelium, which is crucial for effective extension and growth of the branches, Shhcre;Lats mutants showed a multilayered epithelium with cells protruding into the lumen. Gross phenotypes similar to that of our Lats1/2 mutant lungs were described in the kidneys and salivary glands of transgenics with overexpression of nuclear YAP or mutants with deletion of Lats1/2 (Reginensi et al., 2016; Szymaniak et al., 2017). These findings suggest that in branching organs such as the lung, kidney and salivary gland, a primary role of Hippo signaling is to maintain an organized epithelium, which is cardinal for organ size.
The finding that determinants of adhesion and apical-basal polarity were altered in the Shhcre;Lats mutants revealed a feedback mechanism between these determinants and Hippo signaling. Many of these factors that we identified as being altered are also known to be upstream of Hippo signaling, including E-cadherin, which regulates YAP in human breast cancer cells (Kim et al., 2011), and aPKC, which regulates Yki (YAP equivalent in Drosophila) in the eye epithelium (Grzeschik et al., 2010). Similarly, Crb3, an apical-basal polarity determinant, regulates LATS phosphorylation and YAP localization in the developing lung epithelium (Szymaniak et al., 2015). This feedback control allows cells to not only respond to, but also modify, their microenvironment, ensuring coordinated morphogenesis and tissue growth.
This investigation, centered on Lats1/2 mutants, builds on existing studies that have investigated the role of other Hippo pathway members in the developing lung, specifically Mst1/2 and Yap (Lin et al., 2015; Szymaniak et al., 2015; Volckaert et al., 2017; Mahoney et al., 2014; Chung et al., 2013; Lange et al., 2015; Lin et al., 2017). As MST1/2 phosphorylate and activate LATS1/2, one would predict similar phenotypes from Mst1/2 and Lats1/2 epithelial mutants. However, whereas Shhcre;Lats mutants show a halt of branching at E10.5, Shhcre;Mst mutants have minimal branching defects (Lin et al., 2015; Lange et al., 2015). Indeed, LATS level and phosphorylation was not detectably decreased in Mst mutants (Lin et al., 2015). Furthermore, although E-cadherin and epithelial polarity was minimally perturbed in Mst mutants during development, all three Mst1/2 mutant studies showed increased epithelial proliferation (Lin et al., 2015; Chung et al., 2013; Lange et al., 2015), which was not observed in epithelial Lats1/2 mutants. These findings suggest that it is not a linear path from MST1/2 to LATS1/2: LATS1/2 are likely regulated by factors other than MST1/2, and MST1/2 likely control factors in addition to LATS1/2.
Epithelial Yap mutants also exhibited branching defects. However, the epithelium remained largely a monolayer, different from that observed in the Shhcre;Lats mutants. It was suggested that the branching defect in the Shhcre;Yap mutant is due to inability of epithelial cells at the proximal-distal transition zone to respond to TGFβ signaling (Mahoney et al., 2014). However, another study of Yap mutants suggests that YAP controls lung branching by regulating proliferation and mechanical force production instead of proximal-distal patterning (Lin et al., 2017). In Shhcre;Lats mutants, we found that both SOX2 and SOX9 are decreased. The decrease is likely secondary to the earlier loss of apical-basal polarity and monolayer epithelial integrity. Although findings from Shhcre;Lats mutants do not resolve the debate on YAP function in branching, they suggest that MST/LATS/YAP and their co-factors control a complex network of targets.
Multiple lines of evidence support that inactivation of LATS1/2 or MST1/2, leading to accumulation of nuclear YAP, promotes progenitor cell state and inhibits differentiation (Zhao et al., 2014; Lin et al., 2015; Szymaniak et al., 2015; Chung et al., 2013; Lange et al., 2015; Volckaert et al., 2017). Consistent with this, there are increased basal cells, a progenitor cell type, in the trachea and lung of Shhcre;Lats mutants. In contrast, the strikingly precocious and increased expression of markers of AEC1, a lung epithelial cell type at the end of the chain of differentiation, offers an exception to the rule, and led us to reconsider the function of Hippo signaling in controlling cellular response to microenvironment.
Multiple studies have shown that YAP enters the nucleus in response to cell spreading (Lange et al., 2015; Aragona et al., 2013; Halder et al., 2012; Liu et al., 2016). In a pneumonectomy model of compensatory growth following re-section of a lung lobe, a CDC42-based mechanism responds to cell spreading in the alveolar region and sends YAP into the nucleus (Liu et al., 2016). In the airway, epithelial cells that spread out in response to injury recruit integrin-linked kinase, which destabilizes merlin (NF2) and inactivates MST/LATS, leading to increased nuclear YAP (Volckaert et al., 2017). In addition, there is also evidence that cellular flattening leads to loss of apical determinants such as Crb3, downregulation of LATS level and LATS phosphorylation, resulting in reduced YAP phosphorylation and increased accumulation of nuclear YAP (Szymaniak et al., 2015).
Our data from both the Lats1/2 mutant as well as the Sftpc-rtTA;tetO-YAPS127A mutant indicate that nuclear YAP could lead to either increased AEC1s or basal cells, the two ‘flat’ epithelial cell types in the lung. These cells can be specified despite reduced proximal-distal patterning markers. In addition, the AEC1s and basal cells are intermixed in the mutant lung and trachea regions, suggesting that the ability of nuclear YAP to induce these cells is independent of prior proximal-distal patterning. Further evidence suggests that these regulations may be direct. Genome-wide ChIP-Seq in cell lines and embryonic stem cells identified that YAP/TEAD bind enhancer regions of AEC1-specific genes, including Pdpn and Ager (Zhao et al., 2008; Zanconato et al., 2015). A co-immunoprecipitation experiment in basal cells showed that YAP and P63 directly interact, and ChIP-PCR experiments demonstrated that YAP can pull down regulatory regions of the same genes that P63 regulates in basal cells (Zhao et al., 2014). Interestingly, in the Shhcre;Lats mutant, although there is premature AEC1 differentiation, these cells are not squamous as are normal AEC1s. This is consistent with the notion that flat-cell fate can be separated from flat-cell morphogenesis. In the context of the lung, the fact that AEC1s are a terminally differentiated cell type whereas basal cells are progenitors indicates that the function of the Hippo pathway is not along the progenitor/differentiated cell divide. Rather, the Hippo pathway responds to upstream stretch and puts in motion the downstream differentiation program of epithelial cells with squamous morphology, the types of cells that are most sensitive to mechanical forces from the environment.
A previous study showed that in the adult lung following pneumonectomy, Yap is required in AEC2 cells for proliferation and differentiation into AEC1s (Liu et al., 2016). During development, our findings from Yap and Taz loss-of-function mutants suggest that Yap and Taz are required for AEC1 cell fate, but not AEC2 fate or number. This difference likely reflects the distinct requirements for these factors in development versus in adult injury repair.
Perinatally, as the lung transitions from being fluid-filled before birth to air-filled after birth, there is a drastic change of mechanical force in a short period of time. In coordination with the mechanical change, thinning of the distal epithelium from columnar to squamous AEC1 morphology is a crucial step for lung transition to the extra-uterine environment (Li et al., 2018). Large AEC1s tile to form the alveolar epithelial barrier. Their flatness allows close engagement with the capillary network to enable efficient gas exchange. Findings in this study and from others demonstrate that LATS/YAP axis of Hippo signaling is essential for lung function at the moment of first breath.
MATERIALS AND METHODS
Mice
Lats1flox, Lats2flox, Yapflox; Tazflox; tetO-YAPS127A; Shhcre; Sftpc-rtTA and tetO-cre alleles and transgenic lines have been described before (Heallen et al., 2011; Xin et al., 2013; Xin et al., 2011; Camargo et al., 2007; Harfe et al., 2004; Perl et al., 2002a; Perl et al., 2002b). Lats1flox/flox;Lats2flox/flox mice were bred to Actb-cre mice (The Jackson Laboratory, stock L003376) to generate Lats1D/+;Lats2D/+ mice. These mice were then bred to ShhCre mice and the resulting progeny were bred to Lats1flox/flox and Lats2flox/flox to generate epithelial specific knockouts. Spc-rtTA mice were bred to teto-YAPS127A mice, to tetO-cre and Yapflox/flox;Tazflox/flox mice (The Jackson Laboratory, stock 027929) to generate constitutively active YAP mutant and YAP/TAZ conditional knockout mice, respectively.
Immunohistochemistry/immunofluorescent staining
Whole E10.5, E11.5 and E12.5 embryos and lungs of E17.5, E18.5 and postnatal day (P) 0 mice were fixed in 3.7% paraformaldehyde (Electron Microscopy Sciences) diluted in PBS. Samples were either stained as wholemounts using a DAB immunohistochemistry kit (Vector Laboratories) or embedded in paraffin or frozen in OCT (Electron Microscopy Sciences) for sectioning. Whole lungs and sections were immunostained using standard protocols (Branchfield et al., 2017). Primary antibodies used were: rabbit anti-phospho-YAP (1:500; Cell Signaling, 4911S), mouse anti-YAP (1:50; Santa Cruz Biotechnology, sc-101199), rabbit anti-YAP (1:200; Cell Signaling, 14074), rabbit anti-E-cadherin (1:200; Cell Signaling, 3195S), mouse anti-NKX2-1 (1:200; Thermo Fisher Scientific, MA5-13961), rabbit anti-aPKC (1:50; Santa Cruz Biotechnology, sc-208), goat anti-SCRIB (1:50; Santa Cruz Biotechnology, sc-11048), rabbit anti-LAMAα5 (1:200; kind gift of Dr Takako Sasaki, Oita University, Japan), rat anti-ITGB1 (1:200; Millipore, MAB1997), rabbit anti-HOPX (1:100; Santa Cruz Biotechnology, sc-30216), mouse anti-HOPX (1:50; Santa Cruz Biotechnology, sc-398703), Syrian hamster anti-PDPN (1:500; Developmental Studies Hybridoma Bank, 8.1.1.), rabbit anti-WNT5a (1:100; Abcam, ab174963) rabbit anti-pro-SPC (1:200; Seven Hills Bioreagents, WRAB-9337), rabbit anti-cleaved caspase 3 (1:100; Cell Signaling, 9661), rabbit anti-PH3 (1:500; Upstate Cell Signaling Solutions, 9701), mouse anti-SOX2 (1:50; Santa Cruz Biotechnology, sc-365823) rabbit anti-SOX9 (1:500; Millipore, AB5535). Slides were then incubated with FITC- or Cy3-conjugated secondary antibodies (1:200; Jackson ImmunoResearch: Cy3 goat anti-rabbit, 111-165-144; FITC goat anti-rabbit, 111-095-144; Cy3 goat anti-mouse, 115-165-003; FITC donkey anti-goat, 705-545-147; Cy3 goat anti-rat, 112-165-167; Cy3 goat anti-Syrian hamster, 107-165-142). Slides were mounted with Vectashield containing DAPI (Vector Laboratories) and visualized/photographed using a Zeiss AxioImager.A2 microscope and AxioCam MRc camera. Images were processed using Adobe Photoshop and/or ImageJ.
Immunostaining quantification
Three equally spaced, and equivalent slides from either controls or mutants were immunofluorescently stained for HOPX, pro-SPC or PH3. Three 20× (E11.5 PH3) or 40× (p0 PH3, HOPX, pro-SPC) images were taken from similar areas of each slide. For E11.5 PH3 quantification, the number of PH3+ and DAPI+ cells in the epithelium were counted to determine the percentage of proliferating epithelial cells. For P0 PH3, pro-SPC and HOPX quantification, the number immunopositive and DAPI+ cells in the entire 40× field were counted to determine the percentage of positive cells. Statistical significance was determined using Student's t-test.
Quantitative RT-PCR (qRT-PCR)
RNA was isolated from embryonic and postnatal whole lungs using an RNEasy micro or mini kit (Qiagen), respectively, as per the manufacturer's protocol. RNA (0.5 μg) was reverse transcribed into cDNA using Superscript III (Invitrogen). A ‘no RT’ enzyme sample was also prepared and used as a negative control. For qRT-PCR, 0.1-0.33 μl of cDNA was amplified using gene-specific primers and SYBR Green mix (Bio-Rad) on a Bio-Rad MyiQ real-time PCR machine. Data were analyzed using the change in cycle threshold (ΔCt) value method. Statistical significance was determined using Student's t-test. For a list of gene-specific primers, see Table S1.
Whole-mount in situ hybridization
Embryonic lungs were dissected in PBS, fixed in 4% paraformaldehyde overnight at 4°C, and then dehydrated to 100% methanol. Whole-mount in situ hybridization was carried out following established protocols (Abler et al., 2011).
Acknowledgements
We thank Drs Fernando D. Camargo and Eric Olson for sharing mouse lines, and members of the Sun laboratory for constructive discussions and readings of the manuscript.
Footnotes
Author contributions
Conceptualization: L.B.N., X.S.; Methodology: L.B.N., R.L.J., X.S.; Validation: L.B.N., R.E.Y.; Formal analysis: L.B.N., R.E.Y., W.G.P., Y.Z., J.M.V.; Investigation: L.B.N., R.E.Y.; Resources: L.B.N., R.L.J., X.S.; Data curation: R.E.Y.; Writing - original draft: L.B.N., X.S.; Writing - review & editing: L.B.N., R.E.Y., W.G.P., J.M.V., X.S.; Visualization: L.B.N., R.E.Y., X.S.; Supervision: X.S.; Project administration: X.S.; Funding acquisition: R.L.J., X.S.
Funding
This work was supported by a National Institutes of Health postdoctoral training grant to the University of Wisconsin Genetics program (T32 GM007133); a National Heart, Lung and Blood Institute grant (F32 HL132483 to L.B.N.); a National Science Foundation Graduate Research Fellowship Program grant (DGE-1747503 to R.E.Y.); National Heart, Lung, and Blood Institute grants (RO1 HL142215, HL097134, HL122406); and a Wisconsin Partnership Program Grant funded by the School of Medicine and Public Health, University of Wisconsin-Madison (2897 to X.S.). Deposited in PMC for release after 12 months.
References
Competing interests
The authors declare no competing or financial interests.